Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oligonucleotide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis patent CN109053839A enables high-purity nucleoside modifiers. Significant cost reduction and scalable supply chain for antisense drug manufacturing.
Novel synthesis method for high-purity phosphoramidite nucleoside derivatives enabling cost-effective oligonucleotide manufacturing and scalable supply chains for global pharmaceutical partners.
Patent CN113461743A reveals a cost-effective 4-step route for crosslinkable nucleosides, eliminating chromatography and enabling high-purity oligonucleotide manufacturing.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.
Patent CN101899092A reveals a novel solid-phase method for peptide-linker-oligonucleotide conjugates, enhancing cell permeability and simplifying manufacturing for reliable supply.
Novel one-pot synthesis method for high-purity nucleoside dimer phosphoramidites. Reduces steps and reagent costs for oligonucleotide manufacturing.
Patent CN117384226B details a high-purity GalNAc synthesis route offering significant cost reduction and supply chain reliability for oligonucleotide drug manufacturing.